Training

Register now

Virtual meeting

Via Zoom

Description

The Harm Reduction Series is designed to provide caregivers and providers with information on best practices for caring for individuals who are actively using substances. The education series will teach ways to expand the treatment continuum to include engaging and keeping people safe when they are actively using substances including alcohol, opioids, stimulants, and tobacco. The series is designed for a broad range of audiences and each module will be presented with an expert from the community to provide insight regarding strategies for engagement and implementation.

This training will focus on harm reduction techniques for nicotine and tobacco use. Participants will be able to identify evidence-based strategies that may reduce nicotine/tobacco consumption. How to individualize treatment by learning how to modify FDA-approved medications will be discussed. How to identify barriers to smoking cessation among individuals with substance use disorder, from both clinician and patient standpoints will be discussed.

Intended audience

The entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction.

Guest Speaker

Hasmeena Kathuria, MD Vice-Chair of the American Thoracic Society Tobacco Action Committee

Speakers

Hasmeena Kathuria, MD

Dr. Kathuria is a Pulmonary and Critical Care physician at Boston Medical Center and an Associate Professor at Boston University Medical School. Her clinical and research expertise is in developing and directing patient-centered programs in safety-net settings. She developed and directs the Tobacco Treatment Center at Boston Medical Center, a program that brings together a team of health professionals who specialize in helping smokers quit smoking. She is a member of the American Cancer Society Tobacco Cessation Task Group (National Lung Cancer Round Table) to improve implementation of tobacco treatment in lung cancer screening programs and is Vice-Chair of the American Thoracic Society Tobacco Action Committee. She is the Section Editor for UpToDate, Tobacco Treatment section. Her current research, advocacy, and clinical efforts are focused on clinical care and policy surrounding tobacco dependence in underserved populations.

Objectives

• Participants will identify the disparities in smoking prevalence and tobacco-related health disease among patients with substance use disorders (SUD). 
• Participants will describe several barriers to smoking cessation among individuals with SUD, particularly opioid use disorder, from both clinician and patient standpoints.
• Participants will explain how to individualize treatment by learning how to modify FDA-approved medications to facilitate smokers to quit. 

Sponsored by

Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Substance Addiction Services.

Accreditation information

Boston Medical Center grants 1.50 hours to all RNS who attend, complete the evaluation, and complete the post-test. Boston Medical Center is approved as a provider of continuing professional development by the American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Boston University School of Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Boston University School of Social Work which is authorized through the MA state board of Social Work to provide 1.50 CE Credit Hours.

Massachusetts Mental Health Counselors Association, Inc. (MaMHCA) grants 1.50 LMHC CE Credits to LMHCs that attend this activity.

Register now